Session Title: Quick Fire Free Paper Session 02
Session Date/Time: Thursday 26/09/2013 | 14:30-16:00
Paper Time: 15:25
Venue: Hall G1 (Level 2)
First Author: K.Biswas INDIA
To find out whether intravitreal bevacizumab[Avastin] can cause regression of neovascularisation and thus reducing the recurrence of vitreous hemorrhage with early resorption of hemorrhage
tertiary care eye hospital in eastern india
12 patients, all male, aged between 20 to 30 years presenting with fresh vitreous hemorrhage received 0.05ml[ 1.25 mg of bevacizumab in the study eye .fundus photo of 6 patients pre and post injection will be presented.
9 out of 12 patients had a dramatic resolution of vitreous hemorrhage in 3 weeks making further laser therapy possible and early recovery of vision in such young adult males.3 patients had to undergo vitreous surgery.
intravitreal bevacizumab injection is a very useful method of treatment in patients presenting with vitreos hemorrhage in Eales disease. it helps in early recovery of vision in young age group.